PLASMINOGEN ACTIVATORS T-PA, U-PA AND ITS INHIBITOR (PAI) IN NORMAL MALES AND FEMALES

被引:0
|
作者
KOH, SCL
YUEN, R
VIEGAS, OAC
CHUA, SE
NG, BL
SEN, DK
RATNAM, SS
机构
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We determined the plasma levels of tissue plasminogen activator (t-PA), plasminogen activator inhibitor (PAI) activity and their antigen levels including urokinase plasminogen activator (u-PA) in 33 male and 27 female normal subjects. Males had mean t-PA activity of 0.50 iu/ml which was significantly lower (p < 0.01) than the females 0.64 iu/ml. Males had higher (p < 0.001) mean PAI activity (15.5 AU/ml) as compared to females 10.3 AU/ml. The respective mean levels of t-PA and PAI antigen were significantly higher (p < 0.01) in males (8.1 ng/ml and 17.6 ng/ml) than in females (6.2 ng/ml and 12.1 ng/ml), The mean u-PA level in males was 1.54 ng/ml which was significantly higher (p <0.01) than in females with 1.02 ng/ml. In post-venous occlusion studies, females had a greater mean response of 8.6 fold in t-PA activity as compared to males with a mean of 4.5 fold increase. The mean t-PA antigen response in males was 2.0 fold increase as compared to 2.6 fold increase in the females. No significant responses were seen in both sexes in either PAI activity or antigen levels when compared with the resting state. In zymography studies, free t-PA, its inhibitor complexes and u-PA were demonstrated in the euglobulin fractions of stored plasma. This study demonstrates that significant differences in t-PA, u-PA and PAI exist between male and female subjects which should be taken into account when determining their levels in clinical conditions.
引用
收藏
页码:581 / 585
页数:5
相关论文
共 50 条
  • [1] A PLATELET INHIBITOR OF PLASMINOGEN ACTIVATORS - INTERACTIONS WITH T-PA AND U-PA
    BOOTH, NA
    BENNETT, B
    THROMBOSIS AND HAEMOSTASIS, 1985, 54 (01) : 270 - 270
  • [2] Plasminogen activators u-PA, t-PA and its inhibitor PAI-1 in the blood of patients with colorectal cancer
    Kotschy, M
    cZekanowska, E
    Michalski, A
    Alski, B
    Jawien, A
    Tojek, K
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2271 - P2271
  • [3] Plasminogen activators (t-PA, u-PA) and PAI-1 in myeloproliferative diseases
    KremplewskaNalezyta, E
    Rosc, D
    Zastawna, E
    IwanZietek, I
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS195 - PS195
  • [4] The influence of surgery on plasminogen activators (t-PA, u-PA) and its inhibitor (PAI-1) in patients with colorectal adenocarcinoma
    Zekanowska, E
    Jawien, A
    Tojek, K
    Michalski, A
    Alski, B
    Kotschy, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS605 - PS605
  • [5] Plasminogen activators - u-PA, t-PA - And their inhibitor - PAI-1 - In extracts of planoepithelial cells of larynx cancer
    Bialkowska, A
    Michalski, A
    Betlejewski, S
    Burduk, D
    Kotschy, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : P2270 - P2270
  • [6] THE RELEASE OF PLASMINOGEN ACTIVATORS (T-PA AND U-PA) AND PLASMINOGEN-ACTIVATOR INHIBITOR (PAI-1) AFTER VENOUS STASIS
    FALKON, L
    GARI, M
    BORRELL, M
    FONTCUBERTA, J
    BLOOD COAGULATION & FIBRINOLYSIS, 1992, 3 (01) : 33 - 38
  • [7] Plasminogen activators (t-PA, u-PA) and plasminogen activator inhibitor (PAI-1) in synovial fluid from knee joint
    Rosc, D
    Powierza, W
    Zekanowska, E
    Zastawna, E
    Kotschy, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS600 - PS600
  • [8] Plasminogen activators (u-PA, t-PA) and inhibitors (PAI-1, PAI-2) in blood of patients with Graves disease
    Zastawna
    Drewniak, W
    Rosc, D
    Michalski, A
    Kotschy, M
    THROMBOSIS AND HAEMOSTASIS, 1997, : PS606 - PS606
  • [9] Effects of a fucoidan on the activation of plasminogen by u-PA and t-PA
    Nishino, T
    Yamauchi, T
    Horie, M
    Nagumo, T
    Suzuki, H
    THROMBOSIS RESEARCH, 2000, 99 (06) : 623 - 634
  • [10] Discordant expression of mRNA and protein for urokinase and tissue plasminogen activators (u-PA, t-PA) in endometrial carcinoma
    Nordengren, J
    Casslén, B
    Gustavsson, B
    Einarsdottir, M
    Willén, R
    INTERNATIONAL JOURNAL OF CANCER, 1998, 79 (02) : 195 - 201